Author: Ravi Shankar

NeoVolta Reports Fourth Quarter and Fiscal Year 2026 Financial Results

Posted on by Ravi Shankar

58% year-over-year revenue growth to $13.3 million revenue in fiscal year 2026

U.S. BESS manufacturing facility progressing to production ramp-up

SK ON collaboration accelerates capacity expansion with 2027-2031 U.S. domestic cells supply

SAN DIEGO, Sept. 23, 2026 (GLOBE NEWSWIRE) — NeoVolta Inc. (NASDAQ: NEOV) (“NeoVolta” or the “Company”), a U.S.-based energy technology company delivering scalable energy storage solutions, today announced financial results for the fourth quarter and fiscal year ended June 30, 2026.

Fourth Quarter and Fiscal Year 2026 Financial Highlights

  • Fiscal year 2026 revenue increased 58% year-over-year to $13.3 million, compared to $8.4 million in fiscal year 2025, reflecting the Company’s expansion beyond its historical residential base.
  • Fourth quarter revenue was approximately $13.5 thousand, compared to $4.8 million in the fourth quarter of fiscal year 2025, reflecting a substantial decline in residential and traditional installer-channel sales following federal tax law changes in early calendar year 2026.
  • GAAP net loss of $21.5 million, or $(0.55) per share, for fiscal year 2026, compared to a net loss of $5.0 million, or $(0.15) per share, for fiscal year 2025. Fourth quarter GAAP net loss was $11.7 million, compared to $1.6 million in the fourth quarter of fiscal year 2025. Fourth quarter GAAP net loss increase was primarily driven by a $3.9 million provision for credit losses and bad debt expenses and $1.1 million of residential inventory obsolescence reserve.
  • Adjusted EBITDA of $(12.8) million for fiscal year 2026, compared to $(2.6) million for fiscal year 2025. Fourth quarter Adjusted EBITDA was $(8.0) million, compared to $(0.7) million in the fourth quarter of fiscal year 2025. This is the first period for which the Company is disclosing Adjusted EBITDA as a supplemental non-GAAP measure.1
  • Cash and cash equivalents of $22.2 million as of June 30, 2026, plus $3.2 million of restricted cash, for total cash, restricted cash and cash equivalents of $25.4 million, following the Company’s May 2026 public offering.
  • Fiscal year 2026 marked the completion of the Company’s transformation into a multi-market energy storage platform, anchored by the U.S. BESS manufacturing joint venture, NeoVolta Power LLC.


Business Highlights

Fiscal year 2026 was a transformational year for NeoVolta.

  • Launch of NeoVolta Power, LLC, the Company’s 80%-owned Pendergrass, Georgia utility and C&I scale energy storage manufacturing joint venture.
  • Receipt of a formal opinion confirming Foreign Entity of Concern (FEOC) compliance for the Pendergrass facility, the NVApex 5MWh BESS and the NVWave residential product, positioning our products’ eligibility under IRA Section 48E.
  • Expansion of the Company’s commercial pipeline into utility-scale and C&I markets, including a non-binding letter of intent (“LOI”) with Infinite Grid Capital (“IGC”) for approximately 1.1 GWh (representing approximately $200 million in potential deployments) of utility-scale battery systems. Pursuing the LOI, in September, NeoVolta Power entered into a binding capacity reservation agreement with IGC to provide BESS for North Ontario Edge AI datacenter projects for calendar year 2027.
  • Appointment of Jing Nealis as Chief Financial Officer, effective May 18, 2026, further strengthening the Company’s executive leadership team ahead of the production ramp.
  • Subsequent to fiscal year-end, on August 31, 2026, NeoVolta Power announced a five-year strategic supply and manufacturing collaboration with SK On. The collaboration includes a signed agreement for SK On to supply 9 GWh of U.S.-manufactured LFP battery cells to NeoVolta Power from 2027 through 2031, as well as a framework for broader collaboration under which SK On would supply an additional 9 GWh of LFP cells and purchase energy storage packs manufactured by NeoVolta Power from 2027 through 2031. Together, the signed agreement and broader framework are expected to support up to 18 GWh of combined activity between the companies.

Fiscal Year 2027 Key Milestones

  • Complete Site Acceptance Test and commissioning of the Pendergrass, Georgia facility, with production ramp underway from the second quarter of fiscal year 2027.
  • Conversion of non-binding utility-scale and C&I pipeline into binding orders, including the Infinite Grid Capital letter of intent as well as progress toward future order documents contemplated by the broader SK On pack-manufacturing collaboration.
  • Progress toward a second Pendergrass production line, which could scale site capacity toward 8 GWh of annual BESS production capacity in calendar year 2028, supported by the signed SK On cell-supply agreement and the broader pack-manufacturing collaboration framework.
  • Capital allocation priorities for fiscal year 2027 are focused on funding working capital for the production ramp and investment in the second production line. Subsequent to June 30, 2026, the Company entered into a senior secured term loan facility providing $20 million (less an original issue discount of $1.0 million) in initial funding with the potential to increase the aggregate loan commitment by up to an additional $10 million upon mutual agreement of the Company and participating lenders. The facility complements the Company’s broader capital formation strategy to fund the rapid growth in the coming quarters.

Fiscal year 2026 was the year NeoVolta advanced its transformation from a residential battery energy storage company into a multi-market residential, C&I and utility energy storage platform. While our fourth quarter results reflect a difficult period for the U.S. residential energy storage market, we believe we have positioned the company for significant growth with the Pendergrass facility on track to start production ramp-up in the second quarter of fiscal year 2027.

“More importantly, fiscal 2026 was defined by the progress we made at Pendergrass. Our facility is advancing through commissioning and production-ramp activities, and our strategic collaboration with SK On supports our long-term capacity-expansion plans through a multi-year U.S.-manufactured LFP cell-supply agreement and broader pack-manufacturing collaboration. Combined with the growth of our utility-scale and C&I pipeline, we believe NeoVolta enters fiscal year 2027 with a stronger platform to execute our growth strategy,” said Ardes Johnson, Chief Executive Officer of NeoVolta.

“Beginning this quarter, we are introducing Adjusted EBITDA as a supplemental disclosure to provide investors with greater visibility into our underlying operating performance as our business grows. Our balance sheet was strengthened by the completion of our May offering, and subsequent to year-end, we entered into a senior secured term loan facility that provides additional capital for working capital and general corporate purposes. As we enter fiscal year 2027, our focus is on disciplined execution of the Pendergrass production ramp and converting commercial opportunities into durable growth,” said Jing Nealis, Chief Financial Officer of NeoVolta.

Conference Call Information

NeoVolta will host a conference call and webcast on Wednesday, September 23, 2026, at 5:00 p.m. Eastern Time to discuss its fourth quarter and fiscal year 2026 financial and operating results. Management will also discuss recent operational progress and strategic priorities, followed by a question-and-answer session.

  • Date: Wednesday, September 23, 2026
  • Time: 5:00 pm ET
  • Dial-in: +1 (201) 389-0908
  • Webcast and accompanying slide presentation: Registration Link

A telephonic replay will be available from 9:00 p.m. Eastern Time on September 23, 2026, through Wednesday, October 7, 2026. To access the replay, dial +1 (412) 317-6671 and enter replay PIN 13762483.

The webcast replay and accompanying presentation will be available on the Investor Relations section of the Company’s website at neovolta.com/investors.

About NeoVolta

NeoVolta is an innovator in energy storage solutions dedicated to advancing reliable, high-performance power infrastructure for residential, commercial, and utility applications. With a focus on scalable technology, domestic manufacturing, and strategic partnerships, NeoVolta is positioned to support the accelerating transition toward resilient energy systems.

For more information, visit www.neovolta.com.

Cautionary Note Regarding Forward-Looking Statements

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements regarding the production ramp and first commercial production at the Company’s Pendergrass, Georgia facility, potential development of a second Pendergrass production line and the scaling of annual production capacity, the SK Battery America supply agreement and related pack collaboration, expected recovery in residential volumes, conversion of pipeline opportunities into binding orders (including the non-binding Infinite Grid Capital letter of intent), the Company’s senior secured term loan facility, and the Company’s fiscal year 2027 outlook. These statements are based on current expectations and assumptions that are subject to risks and uncertainties, and actual results may differ materially. Factors that could cause actual results to differ include, among others, risks related to the Company’s manufacturing ramp and facility commissioning, joint venture execution, customer order conversion, residential market conditions, changes in federal tax policy or IRA incentive programs, supply arrangements including the SK Battery America collaboration, availability and terms of additional financing, and access to capital, as well as other factors described in the Company’s filings with the U.S. Securities and Exchange Commission, including its most recent Annual Report on Form 10-K and Quarterly Reports on Form 10-Q. The Company undertakes no obligation to update any forward-looking statements, except as required by law.

Non-GAAP Financial Measures

To supplement our financial results presented on a basis in conformity with generally accepted accounting principles in the United States (“GAAP”), we use the non-GAAP measure: Adjusted EBITDA which excludes from our GAAP net loss, interest, taxes, depreciation and amortization, as well as other significant expenses including stock-based compensation that we believe are helpful in understanding our past financial performance. Our non-GAAP financial measures are not meant to be considered in isolation or as a substitute for comparable GAAP measures and should be read only in conjunction with our consolidated financial statements prepared in accordance with GAAP.

Management believes that these non-GAAP financial measures reflect our ongoing business in a manner that allows for meaningful comparisons and analysis of trends in its business, as they exclude expenses and gains not reflective of ongoing operating results or that may be infrequent and/or unusual in nature. We exclude the nonoperating credit loss expenses and loss on debt exchanges as these costs were non-operational in nature and they are not indicative of our ongoing operational results. We also adjust for the effect of stock-based compensation expenses noting that such expenses will recur in future periods. Although stock-based compensation is a key incentive offered to our employees, we continue to evaluate our business performance internally excluding stock-based compensation expenses.

Management also believes that these non-GAAP financial measures provide useful information to investors in understanding and evaluating our operating results and future prospects in the same manner as management and in comparing financial results across accounting periods and to those of peer companies. These non-GAAP measures may not be comparable to similarly titled measures presented by other companies. In this press release, we provided a reconciliation of non-GAAP Adjusted EBITDA to GAAP net loss, the most directly comparable GAAP financial measure.

Contacts

NEOV Investors
Bryan Baritot
Alliance Advisors IR
ir@neovolta.com  

NEOV Media
Email: press@neovolta.com
Phone: 800-364-5464

NEOVOLTA INC.
Consolidated Balance Sheets
           
           
  June 30,     June 30,  
  2026     2025  
Assets              
Current assets:              
Cash and cash equivalents $ 22,201,975     $ 794,836  
Restricted cash   3,150,000       –  
Accounts receivable, net   2,945,468       2,983,841  
Inventory, net   2,133,153       2,137,912  
Prepaid expenses and other current assets (including prepaid inventory in amounts of $931,685 and $535,938, respectively)   2,145,487       748,044  
Other current assets   272,280       –  
Total current assets   32,848,363       6,664,633  
               
Construction in progress   9,602,302       –  
Property and equipment, net   323,804       –  
Net property and equipment   9,926,106       –  
               
Intellectual property (net of accumulated amortization of $333,859)   1,064,641       –  
               
Other assets:              
Lease right-of-use assets, net   8,082,546       140,540  
Prepaid service fee under third party platform   1,631,944       –  
Miscellaneous assets   84,347       –  
               
Total assets $ 53,637,947     $ 6,805,173  
               
Liabilities and Stockholders’ Equity              
Current liabilities:              
Accounts payable – other $ 3,590,368     $ 689,216  
Accounts payable – related party   233,910       –  
Accrued liabilities   1,038,936       78,934  
Lease liabilities   695,269       140,540  
Short-term notes payable   1,120,000       2,603,223  
Total current liabilities   6,678,483       3,511,913  
               
Payable to line of credit lender   –       383,538  
Lease liabilities   7,392,124       –  
Total liabilities   14,070,607       3,895,451  
               
Commitments and contingencies (Note 7)              
               
Stockholders’ equity:              
Common stock, $0.001 par value, 100,000,000 shares authorized, 58,308,247 shares and 34,124,873 shares issued and outstanding, respectively   58,308       34,125  
Additional paid-in capital   86,756,877       28,652,731  
Accumulated deficit   (47,247,845 )     (25,777,134 )
Total stockholders’ equity   39,567,340       2,909,722  
               
Total liabilities and stockholders’ equity $ 53,637,947     $ 6,805,173  

NEOVOLTA INC.
Consolidated Statements of Operations
       
  Three Months Ended June 30,   Year Ended June 30,
  2026   2025   2026   2025
               
Revenues from contracts with customers $ 13,460     $ 4,750,913     $ 13,332,953     $ 8,426,835  
Cost of goods sold   (1,152,857 )     (4,175,474 )     (11,194,753 )     (6,920,130 )
Gross profit   (1,139,398 )     575,439       2,138,199       1,506,705  
                               
Operating expenses:                              
General and administrative   7,974,994       1,929,423       18,347,045       6,065,590  
Research and development   1,036,449       78,417       1,556,043       157,305  
Depreciation and amortization   136,537       –       376,827       –  
Total operating expenses   9,147,980       2,007,840       20,279,915       6,222,895  
                               
Loss from operations   (10,287,378 )     (1,432,401 )     (18,141,716 )     (4,716,190 )
                               
Other income (expense):                              
Loss on debt exchanges   –       –       (1,266,030 )     –  
Interest expense   (22,097 )     (217,372 )     (667,741 )     (320,417 )
Nonoperating credit loss and other   (1,430,837 )     –       (1,532,998 )     –  
Interest income   80,125       139       137,775       2,011  
Total other income (expense)   (1,372,809 )     (217,233 )     (3,328,994 )     (318,406 )
                               
Net loss $ (11,660,188 )   $ (1,649,634 )   $ (21,470,711 )   $ (5,034,596 )
                               
Weighted average shares outstanding – basic and diluted   47,896,780       34,124,873       39,294,032       33,589,818  
                               
Net loss per share – basic and diluted $ (0.24 )   $ (0.05 )   $ (0.55 )   $ (0.15 )

NEOVOLTA INC.
Consolidated Statements of Cash Flows
               
  Year Ended June 30,  
  2026     2025  
Cash flows from operating activities:              
Net loss $ (21,470,711 )   $ (5,034,596 )
Adjustments to reconcile net loss to net cash used in operations:              
Stock compensation expense   4,963,440       2,101,488  
Loss on debt exchanges   1,266,030       –  
Amortization of ROU asset   238,261       80,570  
Depreciation and other amortization expense   411,550       –  
Provision for expected credit losses/bad debt expense   4,580,554       (4,253 )
Inventory obsolescence reserve   1,119,013       –  
Changes in assets and liabilities              
Accounts receivable   (3,005,031 )     (1,630,876 )
Inventory   (834,062 )     41,864  
Prepaid expenses and other current assets   (3,205,228 )     (606,429 )
Other long term assets   (84,347 )     –  
Accounts payable   498,386       683,900  
Accrued expenses   505,735       23,150  
Other changes, net   (175,160 )     (80,570 )
Net cash flows used in operating activities   (15,191,570 )     (4,425,752 )
               
Cash flows from investing activities:              
Additions to construction in progress   (6,364,051 )     –  
Additions to other property & equipment   (767,272 )     –  
Additions to notes receivable   (1,500,000 )     –  
Net cash flows used in investing activities   (8,631,323 )     –  
               
Cash flows from financing activities:              
Proceeds of public equity offerings   35,628,565       –  
Proceeds of private equity offering   13,000,000       1,087,000  
Borrowings under lines of credit   1,370,000       500,000  
Repayments of lines of credit   (633,538 )     (116,462 )
Borrowings under short-term notes payable   6,697,612       5,106,343  
Repayments of short-term notes payable   (7,597,341 )     (2,503,120 )
Prepayment of issuance costs for planned equity offering   (85,266 )     –  
Proceeds from exercise of common stock warrants   –       160,400  
Net cash flows from financing activities   48,380,032       4,234,161  
               
Net increase (decrease) in cash and restricted cash   24,557,139       (191,591 )
Cash, restricted cash and cash equivalents at beginning of period   794,836       986,427  
               
Cash, restricted cash and cash equivalents at end of period $ 25,351,975     $ 794,836  
               
Supplemental disclosures of cash flow information:              
Cash paid for interest $ 863,083     $ 136,580  
Cash paid for income taxes   –       –  
Cash paid for amounts included in operating lease liabilities   250,017       93,190  
Supplemental disclosures of financing and investing activities:              
Issuance of common stock for debt exchanges $ 2,969,524     $ –  
Addition of assets for common stock   998,000       –  
Right-of-use assets obtained for operating lease liabilities   8,184,869       221,110  
Other equity contribution for services   568,800       –  

NEOVOLTA INC.
GAAP to Non-GAAP Reconciliation of Net Loss to Adjusted EBITDA
       
  Three Months Ended June 30,   Year Ended June 30,
  2026   2025   2026   2025
               
Net loss $ (11,660,188 )   $ (1,649,634 )   $ (21,470,711 )   $ (5,034,596 )
Interest expense   22,097       217,372       667,741       320,417  
Interest income   (80,125 )     (139 )     (137,775 )     (2,011 )
Depreciation  and amortization   136,537       –       376,827       –  
Share-based compensation   2,150,677       732,904       4,963,440       2,101,487  
Loss on debt exchanges   –       –       1,266,030       –  
Nonoperating credit loss and other   1,430,837       –       1,532,998       –  
Adjusted EBITDA   (8,000,164 )     (699,497 )     (12,801,449 )     (2,614,703 )

1Adjusted EBITDA is a non-GAAP financial measure. See “Non-GAAP Financial Measures” and the accompanying reconciliation table for further information.

Posted in UncategorizedTagged

Park Dental Partners Expands Arizona Presence with Addition of Sapphire Dental Care

Posted on by Ravi Shankar

MINNEAPOLIS, Sept. 23, 2026 (GLOBE NEWSWIRE) — Park Dental Partners, Inc. (NASDAQ: PARK), a leading dental resource organization, announced that the single practice Sapphire Dental Care and its three (3) doctors joined the Park Dental Partners network of affiliated dental practices effective September 19, 2026. Located in the Phoenix metropolitan area, the affiliation further strengthens the Company’s growing presence in Arizona. Terms of the transaction were not disclosed.

Sapphire Dental Care has built a strong reputation for delivering comprehensive, patient-centered dental care in a welcoming and comfortable environment. The practice offers preventive, general, cosmetic, and restorative dentistry services and is known for its emphasis on communication, advanced technology, and minimally invasive treatment approaches that support long-term oral health.

“Sapphire Dental Care has earned an outstanding reputation for delivering personalized, patient-focused care and building meaningful relationships within the community,” said Pete Swenson, Chief Executive Officer of Park Dental Partners. “We are pleased to welcome the entire Sapphire team to Park Dental Partners and look forward to supporting their continued growth while preserving the values and patient experience that have made the practice so successful for over two decades.”

“Since founding Sapphire Dental Care in 2006, our goal has been to create an environment where patients feel comfortable, informed, and genuinely cared for,” said founder Dr. Manoj Sharma. “Joining Park Dental Partners allows us to maintain the personalized approach our patients have come to expect while gaining access to additional resources and support that will help us continue growing and serving Phoenix’s Litchfield Park community for years to come.”

Continued Growth in Arizona
The addition of Sapphire Dental Care further advances Park Dental Partners’ strategic growth in Arizona and enhances its presence in one of the nation’s fastest-growing markets. The affiliation reflects the Company’s ongoing focus on partnering with high-quality practices that share its commitment to clinical excellence, exceptional service, and community-centered care. The Company now has three (3) practices in Arizona, including two (2) in Phoenix and one (1) in Tucson.

Patients will continue to receive the same trusted care from the Sapphire Dental Care team while benefiting from the additional operational support, resources, and expertise available through Park Dental Partners. The practice remains dedicated to serving families in Litchfield Park and surrounding communities.

“Sapphire is an exceptional and established practice offering comprehensive treatments grounded in clinical excellence, patient trust, and strong community relationships,” said Dr. Chris Steele, Chief Clinical Officer, General Practices, of Park Dental Partners. “Their commitment to high-quality care aligns closely with our mission, and we are excited to partner with them as we expand our presence in Arizona.”

About Park Dental Partners, Inc.
Park Dental Partners, Inc., and its subsidiaries (NASDAQ: PARK) is a dental resource organization that has put patients first since the establishment of its general dentistry group in 1972. The Company provides comprehensive business support services, including clinical team members, administrative personnel, facilities, and equipment, to its affiliated general and multi-specialty dental practices. The Company has 222 affiliated doctors across 88 practice locations in three states. The Company’s clinical support team consists of over 1,000 hygienists, dental assistants, and patient care coordinators that support affiliated doctors in operating their practices. The mission of the Company’s affiliated dental practices since inception has been to ensure patients enjoy the benefits of a lifetime of good oral health. This mission continues to be the driving force behind our organization today.

Park Dental Partners is based in Roseville, Minnesota. For more information, please visit parkdentalpartners.com.

Forward Looking Statements
Certain statements in this press release are “forward‑looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, with respect to the Company’s financial condition, results of operations, plans, objectives, future performance and business. Forward‑looking statements include those preceded by, followed by or that include the words “believes,” “expects,” “anticipates,” “intends,” “estimates,” “plans,” “may,” “will,” or similar expressions. These forward‑looking statements involve risks and uncertainties. Actual results may differ materially from those contemplated by such forward‑looking statements because of, among other things, potential risks and uncertainties, such as:

  • Regulatory and compliance risk, including state dental corporate practice of dentistry and fee‑splitting restrictions, HIPAA and other privacy/cybersecurity obligations, and evolving healthcare and labor regulations;
  • Reimbursement risk, including risks related to payer mix, reimbursement rates, audit/recoupment activity, enrollment and collections timing, and dependence on significant third‑party payors;
  • Our ability to identify, acquire, integrate and effectively support affiliated practices and to execute de novo expansion, and the risk of undiscovered liabilities in acquisitions;
  • Risks related to the proposed transaction, including the risk that required North Carolina dental regulatory clearance may not be obtained or may be obtained subject to conditions and the risk that other closing conditions may not be satisfied or waived;
  • Dependence on affiliated dental practices and their clinical performance; our ability to attract, hire and retain dentists, specialists and hygienists; and risks related to ownership transitions of affiliated entities;
  • Competition for patients and clinicians in our markets and the impact on patient volumes and staffing;
  • Macroeconomic conditions, inflation and interest rates, and our geographic concentration, particularly in the Minnesota area.

A forward‑looking statement is neither a prediction nor a guarantee of future events or circumstances, and those future events or circumstances may not occur. We are under no obligation, and we expressly disclaim any obligation, to update or alter any forward‑looking statements, whether because of new information, future events or otherwise.

Investor Contact: Park Dental Partners Investor Relations Team 763-233-3377 ir@parkdentalpartners.com
Media Contact: Park Dental Partners Media Relations Team 651-633-0500 marketing@parkdentalpartners.com

Posted in UncategorizedTagged

AIR Limited Successfully Prices U.S.$425,000,000 bond

Posted on by Ravi Shankar

DUBAI, United Arab Emirates, Sept. 23, 2026 (GLOBE NEWSWIRE) — AIR Limited (the “Issuer”), a direct wholly owned subsidiary of AIR Global PLC (Nasdaq: AIIR) (the “Company” or “AIR”), has priced senior unsecured notes in an aggregate principal amount of U.S.$425,000,000 (the “Notes”). The Notes have a term of 5 years, maturing in 2031, and a coupon of 7.875% per annum. The Notes will be guaranteed on a senior basis by AIR and certain of the Issuer’s subsidiaries. The Issuer expects to use the gross proceeds from the offering of the Notes (the “Offering”) (i) to repay amounts outstanding under its term loan facility and revolving credit facility, including any accrued and unpaid interest, premiums, fees and expenses payable in connection with such repayment, and (ii) for general corporate purposes, including the payment of fees and expenses incurred in connection with the Offering. The Offering is expected to settle on or around October 1, 2026, subject to customary closing conditions.

About AIR

Founded in 1999 and headquartered in Dubai, AIR is a global consumer brands and innovation company with a presence in more than 90 markets worldwide. Its portfolio reaches millions of adult consumers across social inhalation and modern nicotine categories through brands including Al Fakher (flavored shisha molasses), Crown Switch (closed system pod vaping platform), Crown Gems, and Al Fakher nicotine pouches.

AIR’s strategy combines category-leading brands, scientific research, and in-house innovation capabilities. Strategic investments such as Greentank and royalty-generating intellectual property partnerships such as Crown Bar enhance its participation in fast-growing nicotine and inhalation categories. The Company develops next-generation technologies and products, including OOKA.

By connecting brands, technology, science, and commercial partnerships, AIR is building a differentiated platform positioned to shape the future of adult consumer experiences.

Disclaimer

The securities referred to herein have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended (the “U.S. Securities Act”) or the securities laws of any state of the United States or any other jurisdiction and the securities may not be offered or sold within the United States or to, or for the account or benefit of, U.S. persons, except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the U.S. Securities Act and applicable state or local securities laws of other jurisdictions.

The securities referred to herein are not being offered to the public in the European Economic Area (“EEA”) within the meaning of Regulation (EU) 2017/1129 (the “EU Prospectus Regulation”). In member states of the EEA, this announcement is directed only at persons who are “qualified investors” within the meaning of the EU Prospectus Regulation. This announcement must not be acted on or relied on in any member state of the EEA by persons who are not qualified investors. Any investment or investment activity to which this announcement relates is available only to qualified investors in any member state of the EEA.

The securities referred to herein are not being offered to the public in the United Kingdom within the meaning of Regulation (EU) 2017/1129 as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018 (the “EUWA”) (the “UK Prospectus Regulation”). In the United Kingdom, this announcement is only being distributed to and is only directed at persons who are “qualified investors” within the meaning of the UK Prospectus Regulation who (i) are investment professionals falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (as amended) of the United Kingdom (as amended, the “Order”), (ii) are persons who are high net worth entities falling within Article 49(2)(a) to (d) of the Order or (iii) who are persons to whom an invitation or inducement to engage in investment activity (within the meaning of section 21 of the Financial Services and Markets Act 2000 of the United Kingdom) (as amended, the “FSMA”) in connection with the issue or sale of any Notes may otherwise lawfully be communicated or caused to be communicated (all such persons together being referred to as “Relevant Persons”).

This announcement is directed only at (i) in the United Kingdom, persons who are Relevant Persons and (ii) in any member state of the EEA, persons who are qualified investors. Any investment or investment activity to which this announcement relates is available only to Relevant Persons in the United Kingdom and qualified investors in any member state of the EEA.

The Notes are not intended to be offered, sold or otherwise made available to and should not be offered, sold or otherwise made available to any retail investor in the EEA. For these purposes, a retail investor means a person who is one (or more) of: (i) a retail client as defined in point (11) of Article 4(1) of EU MiFID II; or (ii) a customer within the meaning of Directive (EU) 2016/97 (the “Insurance Distribution Directive”), where that customer would not qualify as a professional client as defined in point (10) of Article 4(1) of EU MiFID II. Consequently, no key information document required by Regulation (EU) No. 1286/2014 (the “EU PRIIPs Regulation”) for offering or selling the Notes or otherwise making them available to retail investors in the EEA has been prepared and therefore offering or selling the Notes or otherwise making them available to any retail investor in the EEA may be unlawful under the EU PRIIPS Regulation.

The Notes are not intended to be offered, sold or otherwise made available to and should not be offered, sold or otherwise made available to any retail investor in the United Kingdom. For these purposes, a retail investor means a person who is one (or more) of: (i) a retail client, as defined in point (8) of Article 2 of Regulation (EU) No. 2017/565 as it forms part of domestic law by virtue of the EUWA; (ii) a customer within the meaning of the provisions of the FSMA and any rules or regulations made under the FSMA to implement the Insurance Distribution Directive, where that customer would not qualify as a professional client, as defined in point (8) of Article 2(1) of Regulation (EU) No. 600/2014 as it forms part of domestic law by virtue of the EUWA. Consequently, no key information document required by Regulation (EU) No. 1286/2014 as it forms part of domestic law by virtue of the EUWA (the “UK PRIIPs Regulation”) for offering or selling the Notes or otherwise making them available to retail investors in the United Kingdom has been prepared and, therefore, offering or selling the Notes or otherwise making them available to any retail investor in the United Kingdom may be unlawful under the UK PRIIPs Regulation.

No Offer or Solicitation

The Offering is being made by means of an offering memorandum. This press release is for informational purposes only and does not constitute (and shall not be construed as) an offer to sell or the solicitation of an offer to buy any securities of AIR Limited, nor shall there be any sale of securities in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

Forward Looking Statements

This press release contains “forward-looking statements” within the meaning of the U.S. Private Securities Litigation Reform Act of 1995 and other U.S. federal securities laws. These forward-looking statements can generally be identified by the use of forward-looking terminology, including the terms “anticipate,” “believe,” “contemplate,” “estimate,” “expect,” “intend,” “may,” “plan,” “predict,” “potential,” “seek,” “should,” “target,” “will,” or, in each case, their negative or other variations or comparable terminology. Forward-looking statements in this press release include, but are not limited to, statements regarding: the expected occurrence of or date of settlement of the Offering; the expected use of proceeds from the Offering; and AIR’s strategy, market position and future business prospects.

Such forward-looking statements are based on available current market material and management’s expectations, beliefs and forecasts concerning future events impacting the Issuer. These statements are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied by the forward-looking statements.

Nothing in this press release should be regarded as a representation by the Issuer that the forward-looking statements will be achieved. Forward-looking statements speak only as of the date they are made, and the Issuer undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law.

Contacts 
AIR Investor Relations:
Gaurav Jain: Gaurav.jain@air.global; +971-56-439-4296
Anuja Shendye: a.shendye@air.global; +971-58-907-8782 investor@air.global

AIR Media Relations:
ICR for AIR
For more information, email inquiries to AIRglobal@icrinc.com

Posted in UncategorizedTagged

Pasqal recognized with an EIC Fund Award at the 2026 TechEU Equity Summit in Luxembourg

Posted on by Ravi Shankar

The award recognizes organizations for their contributions to Europe’s innovation ecosystem and the future of European technology

PARIS, Sept. 23, 2026 (GLOBE NEWSWIRE) — Pasqal (Nasdaq: PSQL), a global leader in neutral-atom quantum computing, today announced that it had received a European Innovation Council (EIC) Fund Award at the 2026 TechEU Equity Summit in Luxembourg. Organized by the European Investment Bank (EIB), the event explored market trends, investment needs and key challenges across deep tech, security and defense, cleantech, and life sciences.

The EIC Fund Awards recognize selected companies in the EIC Fund’s portfolio for their contributions to European deeptech. Pasqal was recognized as one of the first companies in the EIC Fund’s portfolio to complete a SPAC transaction and become a publicly listed company on Nasdaq on August 28. This achievement marks a significant milestone in the Fund’s history and highlights the importance of successful exits in strengthening Europe’s innovation ecosystem.

“As a French company active in a strategic technology sector, Pasqal received early support from European institutions, both for its research and its growth, particularly through the EIC Fund,” said Wasiq Bokhari, CEO of Pasqal. “That backing helped us grow from a research-driven start-up into a company now listed on Nasdaq. We are deeply grateful for the EIC Fund’s confidence in our team, and very proud to receive this award. Our ambition now is to keep scaling from Europe, while extending our impact and partnerships worldwide.”

In addition to receiving the award, Wasiq Bokhari, CEO of Pasqal, moderated a panel discussion during the summit entitled “Exploring Exits Strategy and IPOs – Access to Capital Markets”. Featuring speakers from the EIB, Headline Fund, Atlantic Bridge, and Euronext, the session examined the role of IPOs, public market readiness, and capital market reform in helping scale-ups attract investment, grow, and remain headquartered in Europe.

TechEU Equity is a networking and thought-leadership event bringing together investors, fund managers, founders, and senior tech executives to discuss investment trends, scaling opportunities, and the future of European technology. It focuses on connecting private capital with high-growth companies across sectors such as AI, deeptech, fintech, and climate tech.

Contacts

Investors
investors@pasqal.com 

Media
pr@pasqal.com

About Pasqal
Pasqal (Nasdaq: PSQL) helps organizations tackle problems that are difficult or impossible to solve with conventional computing methods alone. Founded in 2019 on Nobel Prize–winning research, Pasqal builds and operates neutral-atom quantum computers, delivered with a full software stack, for industry, science, and governments. Pasqal’s production-ready systems are available both on-premises and through the cloud, enabling organizations to harness quantum computing without requiring in-house quantum expertise. A single hardware platform supports analog workloads today and is designed to evolve toward fault-tolerant quantum computing in the future.

Headquartered in France with operations globally, Pasqal’s quantum computing systems are used by customers across energy, financial services and advanced materials to address complex challenges. Pasqal’s customers include Saudi Aramco, Crédit Agricole CIB, LG Electronics and supported by partnerships with NVIDIA and IBM (Pasqal is part of the IBM Quantum Network).

Forward-Looking Statements
Certain statements herein may be considered “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements generally are accompanied by words such as “believe,” “may,” “might”, “will,” “estimate,” “continue,” “anticipate,” “intend,” “expect,” “should,” “would,” “could,” “plan,” “predict,” “project”, “forecast,” “potential,” “seem,” “seek,” “target,” “possible,” “future,” “outlook” or similar terminology or expressions that predict or indicate future events or trends. These forward-looking statements include, but are not limited to, statements regarding future events, including Pasqal’s ability to accelerate global deployment of its quantum computing platform.

These statements are based on current expectations and are not predictions of actual performance. They are provided for illustrative purposes only and must not be relied on as a guarantee, prediction or definitive statement of fact or probability. Actual events and circumstances are difficult or impossible to predict and are beyond the control of Pasqal. These statements are subject to known and unknown risks and uncertainties and assumptions regarding Pasqal’s business, and actual results may differ materially. These risks and uncertainties include, but are not limited to: general economic, political, social and business conditions; uncertainty or changes with respect to laws and regulations; risks related to Pasqal’s indebtedness; the risk from Pasqal pursuing an emerging technology, facing significant technical challenges and the potential that it may not achieve commercialization or market acceptance; Pasqal’s reliance on strategic partners and other third parties; Pasqal’s ability to maintain, protect and defend its intellectual property rights; and other risks that will be detailed from time to time in filings with the U.S. Securities and Exchange Commission (the “SEC”). The foregoing list of risk factors is not exhaustive. There may be additional risks that Pasqal does not know or currently believes are immaterial that could also cause actual results to differ from those contained in forward-looking statements. In addition, forward-looking statements provide Pasqal’s expectations, plans and forecasts of future events and views as of the date of this communication. While Pasqal may elect to update these forward-looking statements in the future, Pasqal specifically disclaims any obligation to do so.

Posted in UncategorizedTagged

Saratoga Investment Corp. Prices Public Offering of Additional $20.08 Million 8.00% Notes Due 2031

Posted on by Ravi Shankar

NEW YORK, NY, Sept. 23, 2026 (GLOBE NEWSWIRE) — Saratoga Investment Corp. (the “Company”) (NYSE: SAR) today announced that it has priced an underwritten public offering of an additional $20.08 million in aggregate principal amount of 8.00% unsecured notes due 2031 (NYSE: SAX) (the “Notes”). The Company has granted the underwriters an option to purchase up to an additional $3.0 million in aggregate principal amount of Notes.

The Notes will constitute a further issuance of, have the same terms (except the issue date and the offering price) as, rank equally in right of payment with, and be fungible and form a single series with the $85,000,000 and $12,750,000 in aggregate principal amount of the 8.00% unsecured notes due 2031 that the Company initially issued on August 26, 2026 and September 2, 2026 pursuant to the underwriters fully exercising their over-allotment option, respectively. Upon the issuance of the Notes, the outstanding aggregate principal amount of the Company’s 8.00% unsecured notes due 2031 will be $117,830,325, assuming no exercise of the underwriters’ over-allotment option.

The Notes will mature on August 31, 2031, and may be redeemed in whole or in part at any time or from time to time at the Company’s option on or after August 26, 2028. The Notes will bear interest at a rate of 8.00% per year payable quarterly on February 28, May 31, August 31, and November 30 of each year, beginning November 30, 2026. The offering is expected to close on September 24, 2026, subject to customary closing conditions.

The Company has received an investment grade private rating of “BBB” from Egan-Jones Ratings Company, an independent, unaffiliated rating agency.

Egan-Jones is a Nationally Recognized Statistical Rating Organization (NRSRO) and is recognized by the National Association of Insurance Commissioners (NAIC) as a Credit Rating Provider (CRP). Egan-Jones is also certified by the European Securities and Markets Authority (ESMA).

Lucid Capital Markets, LLC and Oppenheimer & Co. Inc. are serving as joint book-running managers for this offering. The Company expects to use the net proceeds from this offering to repay a portion of the outstanding indebtedness under the special purpose vehicle financing credit facility with Valley National Bank.

Investors are advised to consider carefully the investment objective, risks and charges and expenses of the Company before investing. The preliminary prospectus supplement dated September 22, 2026, the pricing term sheet dated September 23, 2026, and the accompanying prospectus dated March 11, 2026, each of which has been filed with the Securities and Exchange Commission (the “SEC”), contains a description of these matters and other important information about the Company and should be read carefully before investing.

This press release does not constitute an offer to sell or the solicitation of an offer to buy, nor will there be any sale of, the Notes referred to in this press release in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of such state or jurisdiction. A registration statement (File No. 333-292765) relating to the Notes was filed and has been declared effective by the SEC.

This offering is being made solely by means of a written prospectus forming part of the effective registration statement and a related preliminary prospectus supplement, which may be obtained for free by visiting the SEC’s website at www.sec.gov or from any of the following investment banks: Lucid Capital Markets, LLC, Attn: George Mangione, 570 Lexington Avenue, 40th Floor, New York, NY 10022 (telephone number (646) 362-3098), or by e-mailing GMangione@lucidcm.com or Oppenheimer & Co. Inc., Attention: Syndicate Prospectus Department, 85 Broad Street, 26th Floor, New York, NY 10004, by telephone at (212) 667-8055, or by email at EquityProspectus@opco.com.

About Saratoga Investment Corp.

Saratoga Investment Corp. is a specialty finance company that provides customized financing solutions to U.S. middle-market businesses. The Company invests primarily in senior and unitranche leveraged loans and mezzanine debt, and, to a lesser extent, equity to provide financing for change of ownership transactions, strategic acquisitions, recapitalizations and growth initiatives in partnership with business owners, management teams and financial sponsors. The Company’s objective is to create attractive risk-adjusted returns by generating current income and long-term capital appreciation from its debt and equity investments. The Company has elected to be regulated as a business development company under the Investment Company Act of 1940, as amended, and is externally managed by Saratoga Investment Advisors, LLC, an SEC-registered investment advisor focusing on credit-driven strategies. The Company owns two active SBIC-licensed subsidiaries, having surrendered its first license after repaying all debentures for that fund following the end of its investment period and subsequent wind-down. Furthermore, it manages a $350 million collateralized loan obligation (“CLO”) fund that has recently repriced and reset its reinvestment period and co-manages a joint venture (“JV”) that owns a $400 million collateralized loan obligation (“JV CLO”) fund. It also owns 50% of the Class E2R5 notes and 100% of the subordinated notes of the CLO, 87.5% of both the unsecured loans and membership interests of the JV and 87.5% of the Class E-R notes of the JV CLO. The Company’s diverse funding sources, combined with a permanent capital base, enable the Company to provide a broad range of financing solutions.

FORWARD-LOOKING STATEMENTS

Statements included herein contain certain “forward-looking statements” within the meaning of the federal securities laws, including statements with regard to the offering of additional Notes and the anticipated use of the net proceeds of the offering. Forward-looking statements can be identified by the use of forward looking words such as “outlook,” “believes,” “expects,” “potential,” “continues,” “may,” “will,” “should,” “seeks,” “approximately,” “predicts,” “intends,” “plans,” “estimates,” “anticipates” or negative versions of those words, other comparable words or other statements that do not relate to historical or factual matters. The forward-looking statements are based on the Company’s beliefs, assumptions and expectations of future events and its future performance, taking into account all information currently available to the Company. These statements are not guarantees of future events, performance, condition or results and involve a number of risks and uncertainties. Actual results may differ materially from those in the forward-looking statements as a result of a number of factors, including but not limited to an economic downturn or recession and its impact on the ability of the Company’s portfolio companies to operate and the investment opportunities available to it; the uncertainty associated with the imposition of tariffs and trade barriers and changes in trade policy and its impact on the Company’s portfolio companies and the global economy; interest rate volatility, including the uncertainty relating to the interest rate environment; the impact of supply chain constraints; labor shortages; the elevated levels of inflation; and the impact of geopolitical conditions on the Company’s portfolio companies and opportunities available to it, as well as those described from time to time in our filings with the SEC. Any forward-looking statement speaks only as of the date on which it is made. The Company undertakes no duty to update any forward-looking statements made herein, whether as a result of new information, future developments or otherwise, except as required by law.

Contact: Henri Steenkamp
Saratoga Investment Corp.
212-906-7800

Posted in UncategorizedTagged

FAST TRACK GROUP Announces Delisting of Ordinary Shares from The Nasdaq Capital Market; Securities to Remain Trading on the OTC Markets

Posted on by Ravi Shankar

SINGAPORE, Sept. 23, 2026 (GLOBE NEWSWIRE) — FAST TRACK GROUP (OTC: FTRKD) (the “Company”), a leading entertainment-focused event management and celebrity agency company, announced that The Nasdaq Stock Market LLC (“Nasdaq”) will delist the Company’s Class A ordinary shares (the “Shares”) from The Nasdaq Capital Market. Nasdaq will file a Form 25-NSE with the U.S. Securities and Exchange Commission (the “SEC”) to complete the delisting, which will become effective ten days after the Form 25-NSE is filed.

On August 11, 2026, the Company received a determination letter from Nasdaq’s Listing Qualifications Department based on the Company’s failure to satisfy the US$1.00 minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2). Trading of the Shares on Nasdaq was suspended at the opening of business on August 18, 2026. The Company requested a hearing before a Nasdaq Hearings Panel under the Nasdaq Rule 5800 Series, and on September 15, 2026, the company withdrew its appeal on the Staff’s determination. As a result the Hearing before a Panel that was scheduled on September 17, 2026 was cancelled.

On September 17, 2026, Nasdaq announced that it will file a Form 25-NSE with the SEC to complete the delisting of the Company’s Class A ordinary shares from Nasdaq. The delisting will become effective ten days after the Form 25-NSE is filed. 

The Shares have been quoted on the OTC Markets under the symbol “FTRKF” since August 18, 2026, and temporarily as “FTRKD” for twenty business days following the recent 1-for-20 reverse split. The Shares are expected to continue trading on the OTC Markets following the Nasdaq delisting. The Company will remain a reporting company under the U.S. Securities Exchange Act of 1934, as amended, and intends to continue filing its annual report on Form 20-F and furnishing reports on Form 6-K with the SEC.

About FAST TRACK GROUP
FAST TRACK GROUP (OTC: FTRKD) is a leading entertainment-focused event management and celebrity agency company. Since inception in Singapore in 2012, the Company has expanded across Asia Pacific, earning a reputation for being the preferred partner for event and endorsement organizers in the region. FAST TRACK GROUP goes beyond traditional event management, offering value-added services such as technical production planning, celebrity sourcing, celebrity engagement consultancy and event manpower support, all tailored to the highest standards.

Forward-Looking Statements
Certain statements in this announcement are forward-looking statements. These forward-looking statements involve known and unknown risks and uncertainties and are based on the Company’s current expectations. Investors can find many (but not all) of these statements by the use of words such as “approximates,” “believes,” “hopes,” “expects,” “anticipates,” “estimates,” “projects,” “intends,” “plans,” “will,” “would,” “should,” “could,” “may” or other similar expressions. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct. The Company cautions investors that actual results may differ materially from the anticipated results. It encourages investors to read the risk factors contained in the Company’s final prospectus, and other reports it files with the SEC, before making any investment decisions regarding the Company’s securities. The Company undertakes no obligation to update or revise publicly any forward-looking statements to reflect subsequent events or circumstances, or changes in its expectations, except as may be required by law.

Investor Relations Contact
Gateway Group, Inc.
949-574-3860
FTRK@gateway-grp.com

Posted in UncategorizedTagged

Asset Portfolio Briefing: First Gold Production at Cuiú Cuiú, Imminent Gold Production at Amulsar, and Other Positive Updates

Posted on by Ravi Shankar

MONTRÉAL, Sept. 23, 2026 (GLOBE NEWSWIRE) — OR Royalties Inc. (“OR Royalties,” or the “Company”) (OR: TSX & NYSE) is pleased to provide the following select producing, development and exploration asset updates. Amounts presented are in United States dollars, except where otherwise noted.

Select Producing Asset Update Summaries

For additional details on select royalties and streams, please refer to OR Royalties’ 2026 Asset Handbook (link)

  • Cuiú Cuiú (Cabral Gold Inc. (“Cabral”)) – First gold produced at Cuiú Cuiú on September 10, 2026, with mine ramp-up to commercial production expected in the fourth quarter of 2026. A recent C$45 million strategic investment by Alpayana S.A.C. into Cabral will help accelerate the Phase 1 oxide mine, as well as development work on the conceptual Phase 2 hard-rock gold project. OR Royalties owns a 1.0% net smelter return (“NSR”) royalty on Cuiú Cuiú.
  • Amulsar (United Gold) – First gold production at Amulsar is imminent with the mine’s ramp-up toward commercial production still on track for the first half of 2027. OR Royalties, through its wholly-owned subsidiary OR Royalties International Ltd. (“ORI”), owns a gold stream and a silver stream on Amulsar. ORI will purchase (i) refined gold (“Au”) equal to 3.34% of payable Au produced from the mine until delivery of ~82.3 thousand ounces (“koz”) Au (1.31% of payable Au thereafter), and (ii) refined silver (“Ag”) equal to 49.22% of payable Ag produced from the mine until delivery of ~1.03 million ounces (“Moz”) Ag (19.69% of payable Ag thereafter). First stream payments to ORI under the Au and Ag streams are expected late 2027, or the first half of 2028 (Au and Ag price dependent).
  • CSA (Harmony Gold Mining Company Limited (“Harmony”)) – Harmony provided Financial Year 2027 (“FY27”) CSA copper production guidance of 28-30 thousand tonnes (“kt”) copper (“Cu”). Harmony is targeting a production run rate of 40kt Cu per annum by FY29. An updated Mineral Reserve Estimate increased contained copper inventory when compared to the previous Mineral Reserve Estimate. ORI currently owns a 100% Ag stream and a 3.0% Cu stream at CSA.
  • Dalgaranga (Ramelius Resources Limited) – Underground mined tonnage and grades continue to increase: the June 2026 Quarter saw a total of 115kt of ore mined at an average grade of 5.95 grams per tonne (“g/t”) Au from the Never Never underground mine. OR Royalties owns a 1.44% gross revenue (“GR”) royalty on Dalgaranga and a 1.08% GR royalty on some regional tenements (including the Melville project, where OR Royalties owns an additional 1.0% NSR royalty).
  • Bralorne (Talisker Resources Ltd. (“Talisker”)) – In late August, Talisker reported the successful loading and departure of its first ore shipment to Taiwan as part of Talisker’s direct shipping ore strategy at Bralorne. As of August 31, 2026, Bralorne has produced approximately 4.9koz Au from 19,014 tonnes mined at an average grade of 7.99 g/t Au. Results from the Bralorne preliminary economic assessment (“PEA”) were released on September 21, 2026 and contemplated a gradual ramp-up in production during a four-year permitting and construction period, during which rates grow from about 350 tonnes per day (“tpd”) to 1,500tpd at the start of mill commissioning. Following the start of commercial production, the mining rate increases up to a maximum of 2,875tpd for an average of 2,700tpd over the next 14 years. Average annual gold production from the start of mill commissioning in 2031 is expected to be 110koz. OR Royalties owns a 1.7% NSR royalty on Bralorne and the surrounding property. OR Royalties received its first royalty payment from Talisker in April 2025.

Select Development Asset Update Summaries

  • Cariboo (Osisko Gold Group Inc. (“OGG”)) – September 14, 2026 announcement of positive formal construction decision on the Cariboo Gold Project made by OGG’s Board of Directors, with first gold pour expected in the first quarter of 2029 and commercial production in the second half of 2029. OGG also provided a go-forward capital obligation update for Cariboo of C$990 million, supported by total available and proposed estimated sources of capital of up to C$1,637 million, including C$837 million in cash & equivalents as of September 14, 2026. OR Royalties owns a 5.0% NSR royalty on Cariboo.
  • Windfall (Gold Fields Limited (“Gold Fields”)) – Early June signing of the Impact Benefit Agreement with the Cree First Nation of Waswanipi and the Cree Nation Government and the Grand Council of the Crees (Eeyou Istchee). Gold Fields continues to await a recommendation for the issuance of the Environmental Impact Assessment (“EIA”) from the Environmental and Social Impact Review Committee of Québec. Based on engagements with the Government of Québec and the Cree Nation Government, EIA approval is still expected in the second half of 2026, followed by first production in the first half of 2029. OR Royalties owns a 2.0-3.0% NSR royalty on the Windfall project and the surrounding property.
  • Hermosa/Taylor (South32 Ltd.) – The US Forest Service released the Final Record of Decision (“ROD”) for the “Hermosa Critical Minerals Project”, which completes the federal National Environmental Policy Act (“NEPA”) process needed for Hermosa’s ancillary infrastructure development on National Forest Service land following years of environmental study. First production from the Taylor zinc-lead-silver deposit scheduled for the first half of 2028. Zinc prices are currently trading close to four-year highs. OR Royalties owns a 1.0% NSR royalty on zinc and lead sulfide ores produced at Hermosa.
  • South Railroad (Equinox Gold Corp.) – The United States Bureau of Land Management has issued a positive ROD for the South Railroad project in Nevada, marking completion of federal permitting under the NEPA process. With the ROD now issued, early works construction at South Railroad has begun; first production is scheduled for the first half of 2028. ORI owns a 100% Ag stream at South Railroad.
  • San Antonio (Axo Metals Corp.) – The Mexican Federal Environmental Department issued a positive decision approving the Environmental Impact Statement for the San Antonio gold project located in the State of Sonora. This landmark approval grants the primary authorization required for the construction and operation of the mine. ORI owns a 7.15% precious metals stream (Au and Ag) at San Antonio.
  • White Pine North (White Pine Copper LLC (“WPC”)) – September 21, 2026 announcement of Pre-Feasibility Study results from White Pine North (“WPN”), including a Probable Mineral Reserve of 137.9 million tonnes (“Mt”) grading 1.04% Cu and 16.02 g/t Ag, and a 26-year mine plan with steady-state production of 5.4Mt of ore per year and more than 45kt of payable Cu per year. All major permit applications have been submitted for review by the Michigan Department of Environment, Great Lakes, and Energy. WPC is targeting a Final Investment Decision in the second half of 2027 and commercial production in 2030. OR Royalties currently owns a 1.5% NSR royalty on Cu production from WPN. OR Royalties also currently owns a sliding scale royalty on silver production at WPN at a rate of 12.5% which increases to 15% at a copper price at or above $4.50 per pound Cu and further increases by 5% for every $0.075 per pound increment in copper price to a maximum of 100%.
  • Eagle (PricewaterhouseCoopers (“Receiver”)) – The Receiver confirmed in early July that the exclusivity period would be extended by an additional 90 days to allow Boroo Pte Ltd. to continue its due diligence, negotiate the terms of a potential purchase agreement and continue discussions with the Yukon Government and the First Nation of Na-Cho Nyäk Dun on the key agreements required for the sale of the Eagle Gold Mine to proceed. OR Royalties owns a 5.0% NSR royalty on Eagle.

Select Exploration Asset Update Summaries

  • Glenburgh (Benz Mining Corp. (“Benz”)) – Closing of an A$150 million private placement to accelerate the current 450,000-metre (“m”) drill program; an initial Mineral Resource Estimate is targeted for the first half of 2027. Benz has outlined an Exploration Target of 10.1-12.0Moz contained gold. OR Royalties owns a 1.08% GR royalty on Glenburgh, which also extends over Mt Egerton.
  • Ritz (Torque Metals Limited) – Reported high-grade RC drilling assay results from the HHH deposit at Ritz; notably, 11.0m grading 456.0 g/t Au from 122.0m down hole. OR Royalties owns a 2.0% NSR royalty on Ritz (formerly Paris).
  • Woodjam (Vizsla Copper Corp.) – Drilling intersected intervals of strong porphyry-related mineralization at the Deerhorn deposit: 266.0m of 0.97% Cu, 0.06 g/t Au, and 4.29 g/t Ag from 306.0m down hole; including 48.5m of 3.32% Cu, 0.23 g/t Au, and 16.59 g/t Ag from 320.5m down hole. OR Royalties owns a 2.0% NSR royalty on Woodjam.
  • Shovelnose (Westhaven Gold Corp. (“Westhaven”)) – Westhaven reported highlight drillhole assay results including 10.0m grading 12.2 g/t Au and 103.0 g/t Ag located below the proposed mine development in the 2025 Shovelnose PEA. OR Royalties owns a 2.0% NSR royalty on Shovelnose.
  • Japan Gold Portfolio (Japan Gold Corp. (“JPG”)) – September 23, 2026 announcement regarding the formation of a strategic alliance with Solidcore Resources plc (“Solidcore”), whereby Solidcore has committed to funding $35 million on five initial areas of the JPG portfolio. OR Royalties has agreed to exercise its right to acquire an additional 0.5% royalty on all properties in consideration for $3 million, resulting in the increase of its existing royalty interest from 1.5% to 2.0%.

Jason Attew, President & CEO of OR Royalties, commented: “Our partners showed no signs of slowing down over the past few months, with many positive updates having surfaced across our asset portfolio over the same period. First, congratulations to Cabral on getting Cuiú Cuiú into production, and congratulations to the team at United Gold for being on the cusp of the same incredible achievement at Amulsar; we look forward to the operational ramp-ups at both new mines and the resulting GEOs delivered to OR Royalties.

“Our February 2026 acquisition of the Gold Fields royalty portfolio continues to pay dividends: production at Buenaventura’s San Gabriel mine in Peru continues to ramp up, while some of the royalties acquired on earlier-stage assets in that portfolio, such as Ritz and Woodjam, are benefitting from some extraordinary exploration results. Separately, with additional equity financing recently secured, Benz Mining is accelerating its 450,000m exploration program at Glenburgh, one of the largest exploration programs of its kind in the world.

“Finally, ample positive portfolio catalysts are expected before year-end 2026, including material updates from Canadian Malartic, Mantos Blancos, and Island Gold, amongst others.”

Sources for Technical Information:

Cuiú Cuiú

Amulsar

CSA

Dalgaranga

Bralorne

Cariboo

Windfall

Hermosa

South Railroad

San Antonio

White Pine North

Eagle

Glenburgh

Ritz

Woodjam

Shovelnose

Japan Gold Portfolio


Qualified Person

The scientific and technical content of this news release has been reviewed and approved by Guy Desharnais, Ph.D., P.Geo., Vice President, Project Evaluation at OR Royalties Inc., who is a “qualified person” as defined by National Instrument 43-101 – Standards of Disclosure for Mineral Projects (“NI 43-101”).

About OR Royalties Inc.

OR Royalties is a precious metals royalty and streaming company focused on Tier-1 mining jurisdictions defined as Canada, the United States, and Australia. OR Royalties commenced activities in June 2014 with a single producing asset, and today holds a portfolio of over 200 royalties, streams and similar interests. OR Royalties’ portfolio is anchored by its cornerstone asset, the 3-5% net smelter return royalty on Agnico Eagle Mines Ltd.’s Canadian Malartic Complex, one of the world’s largest gold mines.

OR Royalties’ head office is located at 1100 Avenue des Canadiens-de-Montréal, Suite 300, Montréal, Québec, H3B 2S2.

For further information, please contact OR Royalties Inc.:
Grant Moenting
Vice President, Capital Markets
Cell: (365) 275 1954
Email: gmoenting@ORroyalties.com		 Heather Taylor
Vice President, Sustainability and Communications
Tel: (647) 477 2087
Email: htaylor@ORroyalties.com


Forward-Looking Statements

Certain statements contained in this press release may be deemed “forward-looking statements” within the meaning of the United States Private Securities Litigation Reform Act of 1995, as amended, and “forward-looking information” within the meaning of applicable Canadian securities legislation. Forward-looking statements are statements other than statements of historical fact, that address, without limitation, future events, that exploration, development and growth catalysts announced by operators of the properties in which the Company holds an interest will be achieved as planned and in a timely manner, that additional material updates on Canadian Malartic, Mantos Blancos and Island Gold will be provided by the respective operators in a timely manner and that such catalysts and updates will continue to positively impact OR Royalties. Forward-looking statements are statements that are not historical facts and are generally, but not always, identified by the words “expects”, “plans”, “anticipates”, “believes”, “intends”, “estimates”, “projects”, “potential”, “scheduled” and similar expressions or variations (including negative variations), or that events or conditions “will”, “would”, “may”, “could” or “should” occur. Forward-looking statements are subject to known and unknown risks, uncertainties and other factors, most of which are beyond the control of OR Royalties, and actual results may accordingly differ materially from those in forward-looking statements. Such risk factors include, without limitation, (i) with respect to properties in which OR Royalties holds a royalty, stream or other interest (collectively an “Interest”), risks related to: (a) the operators of the properties, (b) timely development, permitting, construction, commencement of production, ramp-up (including operating and technical challenges), (c) differences in rate and timing of production from Mineral Resource Estimates or production forecasts by operators, (d) differences in conversion rate from Mineral Resources to Mineral Reserves and ability to replace Mineral Resources, (e) the unfavorable outcome of any challenges or litigation relating to title, permit or license, (f) hazards and uncertainty associated with the business of exploration, development and mining including, but not limited to unusual or unexpected geological and metallurgical conditions, slope failures or cave-ins, flooding and other natural disasters or civil unrest or other uninsured risks, (ii) with respect to other external factors: (a) fluctuations in the prices of the commodities that drive royalties, streams, offtakes and investments held by OR Royalties, (b) a trade war or new tariff barriers, (c) fluctuations in the value of the Canadian dollar relative to the U.S. dollar, (d) regulatory changes by national and local governments, including permitting and licensing regimes and taxation policies, regulations and political or economic developments in any of the countries where properties in which OR Royalties holds an Interest are located or through which they are held, (e) continued availability of capital and financing and general economic, market or business conditions, and (f) responses of relevant governments to infectious disease outbreaks and the effectiveness of such response and the potential impact of such outbreaks on OR Royalties’ business, operations and financial condition; (g) geopolitical instability; (iii) with respect to internal factors: (a) business opportunities that may or may not become available to, or are pursued by OR Royalties, (b) the integration of acquired assets or (c) the determination of OR Royalties’ PFIC status. The forward-looking statements contained in this press release are based upon assumptions management believes to be reasonable, including, without limitation: the absence of significant change in OR Royalties’ ongoing income and assets relating to determination of its PFIC status, and the absence of any other factors that could cause actions, events or results to differ from those anticipated, estimated or intended and, with respect to properties in which OR Royalties holds an Interest, (i) the ongoing operation of the properties by the owners or operators of such properties in a manner consistent with past practice and with public disclosure (including forecast of production), (ii) the accuracy of public statements and disclosures made by the owners or operators of such underlying properties (including expectations for the development of underlying properties that are not yet in production), (iii) no adverse development in respect of any significant property, (iv) that statements and estimates relating to mineral reserves and resources by owners and operators are accurate and (v) the implementation of an adequate plan for integration of acquired assets.

For additional information on risks, uncertainties and assumptions, please refer to the most recent Annual Information Form of OR Royalties filed on SEDAR+ at www.sedarplus.ca and EDGAR at www.sec.gov which also provides additional general assumptions in connection with these statements. OR Royalties cautions that the foregoing list of risks and uncertainties is not exhaustive. Investors and others should carefully consider the above factors as well as the uncertainties they represent and the risk they entail. OR Royalties believes that the assumptions reflected in those forward-looking statements are reasonable, but no assurance can be given that these expectations will prove to be accurate as actual results and prospective events could materially differ from those anticipated in such forward-looking statements and such forward-looking statements included in this press release are not a guarantee of future performance and should not be unduly relied upon. In this press release, OR Royalties relies on information publicly disclosed by other issuers and third parties pertaining to its assets and, therefore, assumes no liability for such third-party public disclosure. These statements speak only as of the date of this press release. OR Royalties undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, other than as required by applicable law.

Posted in UncategorizedTagged

SRX Global CEO Kent Cunningham and President of EMJX Platform Eric Jackson to Present at Webull Corporate Connect Series Fintech Investment Webinar

Posted on by Ravi Shankar

NORTH PALM BEACH, Fla., Sept. 23, 2026 (GLOBE NEWSWIRE) — SRX Global Inc. (NYSE American: SRXH) (the “Company” or “SRX”), an AI-enabled platform dedicated to generating long-term shareholder value through investments in high-conviction operating companies and strategic assets, today announced that SRX Global’s CEO, Kent Cunningham, and President, EMJX Platform and Head of Asset Management, Eric Jackson, will present at the Webull Corporate Connect Series Fintech Investment Webinar, a live investor webinar hosted on the Webull platform, on September 30, 2026.

Webull Corporate Connect Series Fintech Investment Webinar
Date: Wednesday, September 30, 2026
Time: 1:00 p.m. ET
Speakers: Kent Cunningham, CEO, SRX Global Inc., Eric Jackson, President, EMJX Platform and Head of Asset Management

Interested parties may register for the webinar at webull.com/webinar. Registration is also available directly within the Webull mobile app. A Webull account is required to register and to access the live session; account setup is free and available to the public.

A replay of the webinar will be available on the Webull platform.

About SRX Global Inc.
SRX Global is an AI-driven platform focused on generating long-term shareholder value through investments in high-conviction operating companies, strategic assets, and technology-enabled opportunities. The Company leverages proprietary technology, data analytics, and disciplined capital allocation to identify and manage investments across multiple sectors.

Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as “believe,” “expect,” “intend,” “aim,” “plan,” “may,” “could,” “target,” and similar expressions are intended to identify forward-looking statements, including statements regarding the timing, format, and content of the referenced webinar. These statements are based on current expectations and assumptions that are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied, including risks described in the Company’s filings with the Securities and Exchange Commission. Forward-looking statements speak only as of the date made, and the Company undertakes no obligation to update them, except as required by law.

Company Contact
SRX Global Inc.
Kent Cunningham, Chief Executive Officer

Investor Relations Contact
KCSA Strategic Communications
Valter Pinto, Managing Director
212-896-1254
srx@kcsa.com 

Posted in UncategorizedTagged

Mineralys Therapeutics’ Transform-HTN Open-Label Extension Trial Data Selected for Late-Breaking Presentation at American Heart Association Scientific Sessions 2026

Posted on by Ravi Shankar

RADNOR, Pa., Sept. 23, 2026 (GLOBE NEWSWIRE) — Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a biopharmaceutical company focused on developing medicines to target hypertension and aldosterone-related adverse outcomes in comorbid conditions such as chronic kidney disease (CKD), obstructive sleep apnea (OSA) and other diseases driven by dysregulated aldosterone, today announced that new long-term efficacy and safety data from the Company’s ongoing Transform-HTN open-label extension trial of the aldosterone synthase inhibitor lorundrostat will be featured in a late-breaking science presentation at the American Heart Association Scientific Sessions 2026, taking place November 6-9 in Chicago, IL.

Details for the Presentation:

Title: Transform-HTN: Long-Term Efficacy and Safety of Lorundrostat, a Novel
Aldosterone Synthase Inhibitor, in Uncontrolled Hypertension
 
Presenter: Manish Saxena MBBS, Deputy Clinical Co-Director of Queen Mary
University of London’s William Harvey Heart Centre, and Hypertension
Specialist at Barts Health NHS Trust
 
Session Time: Sunday, November 8, 3:30 pm CT
 
Session Title: Old Meds, New Meds and BP Goals: Optimizing Antihypertensive
Therapy
 
Session Location: Learning Studio 2, Science and Technology Hall, South Hall
 

About Transform-HTN

Transform-HTN (NCT05968430) is a global open-label extension trial designed to assess the safety, efficacy and tolerability of lorundrostat in participants with hypertension, and includes participants who completed one of three eligible parent studies (Advance-HTN, Launch-HTN or Explore-CKD). Eligible participants were enrolled in the open-label extension study, with a primary endpoint of the change in automated office systolic blood pressure.

About Hypertension
Having sustained, elevated blood pressure (BP) (or hypertension) increases the risk of heart disease, heart attack and stroke, which are leading causes of death in the United States. In 2022, more than 685,000 deaths in the United States included hypertension as a primary or contributing cause. Hypertension and related health issues resulted in an estimated annual economic burden of about $219 billion in the United States in 2019.

Less than 50% of hypertensive patients achieve their BP goal with currently available medications. Dysregulated aldosterone levels are a key factor in driving hypertension in approximately 30% of all hypertensive patients.

About Lorundrostat

Lorundrostat is an investigational, proprietary, orally administered, highly selective aldosterone synthase inhibitor being developed for the treatment of uncontrolled hypertension (uHTN) or resistant hypertension (rHTN), as well as related comorbidities, such as CKD, OSA and other diseases driven by dysregulated aldosterone. Lorundrostat was designed to reduce aldosterone levels by inhibiting CYP11B2, the enzyme responsible for its production. Lorundrostat has 374-fold selectivity for aldosterone-synthase inhibition versus cortisol-synthase inhibition in vitro, has an observed half-life of 10-12 hours and demonstrated a 40-70% reduction in plasma aldosterone concentration in participants with hypertension.

Mineralys has completed six late-stage clinical trials of lorundrostat supporting its efficacy and safety profile while also validating aldosterone as an integral therapeutic target in uHTN and rHTN. The clinical program includes two pivotal, registrational trials, the Phase 3 Launch-HTN trial and Phase 2 Advance-HTN trial, which support the robust, durable and clinically meaningful reductions in systolic blood pressure by lorundrostat. Lorundrostat was well tolerated in both trials with a favorable safety profile.

About Mineralys

Mineralys Therapeutics is a biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as chronic kidney disease, obstructive sleep apnea and other diseases driven by dysregulated aldosterone. Its initial product candidate, lorundrostat, is an investigational, proprietary, orally administered, highly selective aldosterone synthase inhibitor. Mineralys is based in Radnor, Pennsylvania, and was founded by Catalys Pacific. For more information, please visit https://mineralystx.com. Follow Mineralys on LinkedIn, X and Bluesky.

Forward-Looking Statements

Mineralys Therapeutics cautions you that statements contained in this press release regarding matters that are not historical facts are forward-looking statements. The forward-looking statements are based on Mineralys’ current beliefs and expectations and include, but are not limited to, statements regarding the potential therapeutic benefits of lorundrostat. Actual results may differ from those set forth in this press release due to the risks and uncertainties inherent in Mineralys’ business, including, without limitation: any delays in the Food and Drug Administration’s (FDA) review of Mineralys’ accepted new drug application (NDA), including as a result of a government shutdown or reductions in agency funding or personnel; the results of Mineralys’ clinical trials, including the Launch-HTN and Advance-HTN trials, may not be deemed sufficient by the FDA to serve as the basis for regulatory approval of lorundrostat; later developments with the FDA may be inconsistent with the feedback from prior meetings, including whether the proposed pivotal program will support registration of lorundrostat following the FDA’s review of Mineralys’ NDA submission; the risk that future funding under the secured debt facility may not be available on the timeframe Mineralys expects, or at all, including as a result of its failure to meet the conditions required for such funding or failure to comply with the affirmative and negative covenants under the debt facility; Mineralys may not be able to reach agreement on the proposed termination of its license agreement with Tanabe on its expected timeframe, or at all; Mineralys’ future performance is dependent entirely on the success of lorundrostat; potential delays in the commencement, enrollment and completion of clinical trials and nonclinical studies; Mineralys’ dependence on third parties in connection with manufacturing, research and clinical and nonclinical testing; unexpected adverse side effects or inadequate efficacy of lorundrostat that may limit its development, regulatory approval and/or commercialization; unfavorable results from clinical trials and nonclinical studies; results of prior clinical trials and studies of lorundrostat are not necessarily predictive of future results; macroeconomic trends and uncertainty with regard to high interest rates, elevated inflation, tariffs and other trade policies, and the potential for a local and/or global economic recession; Mineralys’ ability to maintain undisrupted business operations due to any pandemic or future public health concerns; regulatory developments in the United States and foreign countries; Mineralys’ reliance on its exclusive license with Tanabe to provide Mineralys with intellectual property rights to develop and commercialize lorundrostat; and other risks described in Mineralys’ filings with the Securities and Exchange Commission (SEC), including under the heading “Risk Factors” in its annual report on Form 10-K, and any subsequent filings with the SEC. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof, and Mineralys undertakes no obligation to update such statements to reflect events that occur or circumstances that exist after the date hereof. All forward-looking statements are qualified in their entirety by this cautionary statement, which is made under the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.

Contact:

Investor Relations
investorrelations@mineralystx.com

Media Relations
Melyssa Weible
Elixir Health Public Relations
Email: mweible@elixirhealthpr.com

Posted in UncategorizedTagged

Zscaler to Host Investor Day on October 6

Posted on by Ravi Shankar

SAN JOSE, Calif., Sept. 23, 2026 (GLOBE NEWSWIRE) — Zscaler, Inc. (NASDAQ: ZS), the cybersecurity platform for the AI era, today announced that it will host its Investor Day in New York City on Tuesday, October 6, 2026, at 8:30 a.m. Eastern Time. The half-day event will feature presentations from members of Zscaler’s leadership team on the company’s vision, strategy, long-term growth drivers, and financial outlook.

Registration for the live webcast can be found at https://ir.zscaler.com/events/event-details/zscaler-investor-day-2026. A replay will be available on Zscaler’s Investor Relations website after the event concludes.

About Zscaler
Zscaler (NASDAQ: ZS) accelerates digital transformation so customers can be more agile, efficient, resilient, and secure. The Zscaler Zero Trust Exchange™️ platform protects thousands of customers from cyberattacks and data loss by securely connecting users, devices, and applications in any location. Distributed across 200+ public data centers globally and thousands of private sites at the edge, the SASE-based Zero Trust Exchange is the world’s largest in-line cloud security platform.

Media Contact
Nick Gonzalez
press@zscaler.com

Investor Relations Contact:
Kim Watkins
ir@zscaler.com

Posted in UncategorizedTagged
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.